Successful Treatment of Keloids and Hypertrophic Scars With Systemic and Intralesional Dupilumab
J Drugs Dermatol. 2023 Dec 1;22(12):1220-1222. doi: 10.36849/JDD.6385.ABSTRACTKeloids and hypertrophic scars negatively impact the quality of life for millions of people in the world. Unfortunately, though many thera-peutic approaches are used to treat scars, they are often limited in efficacy with high rates of recurrence. Lately, a better understanding of the immune dysregulation of several dermatologic conditions has led to the emergence of multiple cytokine-targeted therapies for numerous conditions. Several studies have implicated T helper 2 (Th2) immune dysregulation in the development of scars and keloids, with inte...
Source: Herpes - December 5, 2023 Category: Infectious Diseases Authors: Michelle S Min Daniel R Mazori Michelle S Lee Joseph F Merola Ruth Ann Vleugels Gabriela Cobos Avery H LaChance Source Type: research
Successful Treatment of Keloids and Hypertrophic Scars With Systemic and Intralesional Dupilumab
J Drugs Dermatol. 2023 Dec 1;22(12):1220-1222. doi: 10.36849/JDD.6385.ABSTRACTKeloids and hypertrophic scars negatively impact the quality of life for millions of people in the world. Unfortunately, though many thera-peutic approaches are used to treat scars, they are often limited in efficacy with high rates of recurrence. Lately, a better understanding of the immune dysregulation of several dermatologic conditions has led to the emergence of multiple cytokine-targeted therapies for numerous conditions. Several studies have implicated T helper 2 (Th2) immune dysregulation in the development of scars and keloids, with inte...
Source: Journal of Drugs in Dermatology - December 5, 2023 Category: Dermatology Authors: Michelle S Min Daniel R Mazori Michelle S Lee Joseph F Merola Ruth Ann Vleugels Gabriela Cobos Avery H LaChance Source Type: research
